Tissueblue 0.025% syringe 0.5ML

Ended Awarded

Contract number
SPE2DB25FX1XY
Awardee
Awarding agency
Obligated
$3,309

Award facts

Contract value 100% obligated
$3,308.88 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA). The contract is for the supply of TISSUEBLUE 0.025% SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $3,308.88 and an ultimate completion date of July 7, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois, that specializes in providing a range of pharmaceutical products to federal agencies, particularly the military healthcare system. The company has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which allows the agency to issue firm fixed-price delivery orders for a comprehensive portfolio of pharmaceutical items. This contract position establishes DMS Pharmaceutical Group Inc. as a crucial supplier in the federal pharmaceutical supply chain.

Quick answers

Who was awarded contract SPE2DB25FX1XY?

SPE2DB25FX1XY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 12, 2025.

How much is contract SPE2DB25FX1XY worth?

The government has obligated $3,309 on SPE2DB25FX1XY.

Is contract SPE2DB25FX1XY an order under another contract?

Yes. SPE2DB25FX1XY is a delivery order under SPE2DB22D9353, an indefinite delivery contract.

Was contract SPE2DB25FX1XY competed?

The extent of competition for SPE2DB25FX1XY was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award